Literature DB >> 21627649

Understanding the differences in prevalence of epilepsy in tropical regions.

Luce-Perrine Yemadje1, Dismand Houinato, Fabrice Quet, Michel Druet-Cabanac, Pierre-Marie Preux.   

Abstract

Epilepsy is a frequent chronic neurologic disorder that affects nearly 70 million people worldwide. The majority of people with epilepsy live in developing countries, where epilepsy remains a major public health problem. Wide prevalence differences exist among various populations across sub-Saharan Africa, Latin America, and Asia. In particular, prevalence is lower in Southeast Asia than in sub-Saharan Africa and Latin America. Methodologic problems alone do not seem to explain these differences shown in recent review papers. The distribution of numerous risk or etiologic factors such as infectious diseases with neurologic sequel, head injuries, or genetic factors could explain these differences. Stigmatization of people with epilepsy could lead to underestimating the prevalence of epilepsy, even in well-conducted studies. It is important to standardize the process of epidemiologic monitoring of epilepsy in order to improve the reliability in data comparison. Understanding the reasons for these differences is a crucial issue for eventually raising new hypotheses or prevention strategies. Wiley Periodicals, Inc.
© 2011 International League Against Epilepsy.

Entities:  

Mesh:

Year:  2011        PMID: 21627649     DOI: 10.1111/j.1528-1167.2011.03099.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  28 in total

1.  Anti-epileptic activity of Nelumbo nucifera fruit.

Authors:  Muhammad Ali Rajput; Rafeeq Alam Khan; Tahira Assad
Journal:  Metab Brain Dis       Date:  2017-08-03       Impact factor: 3.584

Review 2.  Epidemiology, causes, and treatment of epilepsy in sub-Saharan Africa.

Authors:  Awa Ba-Diop; Benoît Marin; Michel Druet-Cabanac; Edgard B Ngoungou; Charles R Newton; Pierre-Marie Preux
Journal:  Lancet Neurol       Date:  2014-10       Impact factor: 44.182

Review 3.  Epilepsy treatment in sub-Saharan Africa: closing the gap.

Authors:  J H Chin
Journal:  Afr Health Sci       Date:  2012-06       Impact factor: 0.927

4.  Evaluation of some neuropharmacological effects of Caladium bicolor aiton (araceae) leaf extracts in mice.

Authors:  Abigail M Akhigbemen; Raymond I Ozolua; Enitome E Bafor; Emmanuel O Okwuofu
Journal:  Metab Brain Dis       Date:  2019-02-07       Impact factor: 3.584

Review 5.  Patient heal thyself: modeling and treating neurological disorders using patient-derived stem cells.

Authors:  Kevin C Ess
Journal:  Exp Biol Med (Maywood)       Date:  2013-03

6.  Prevalence of active convulsive epilepsy in an urban slum in Enugu South East Nigeria.

Authors:  Birinus Adikaibe Ezeala-Adikaibe; Casmir Orjioke; Oluchi Ekenze; Uchenna Ijoma; Obinna Onodugo; Orakwue Molokwu; Peter Chime; Nkiru Mbadiwe; Eddy Aneke; Chinwe Onyekonwu; Grace Okudo; Celestine Okwara; Godwin Onyebueke; Ifeoma Ulasi
Journal:  Seizure       Date:  2016-01-07       Impact factor: 3.184

7.  An epidemiological survey of epilepsy in tropical rural areas of China.

Authors:  Guoxian Zheng; Futao Li; Yongmin Chen; Huijuan Liu; Shurong Wang; Jitong Lao; Shuang Chen; Yimin Zhang; Rui Lu; Xiaoping Liao; Lin Ma; Qifu Li
Journal:  Epilepsia Open       Date:  2021-03-02

8.  Addressing the treatment gap and societal impact of epilepsy in Rwanda--Results of a survey conducted in 2005 and subsequent actions.

Authors:  Fidèle Sebera; Naasson Munyandamutsa; Dirk E Teuwen; Ibrahim Pierre Ndiaye; Amadou Gallo Diop; Azita Tofighy; Paul Boon; Peter Dedeken
Journal:  Epilepsy Behav       Date:  2015-04-30       Impact factor: 2.937

9.  An estimate of the prevalence of epilepsy in Sub-Saharan Africa: A systematic analysis.

Authors:  Abigail Paul; Davies Adeloye; Rhiannon George-Carey; Ivana Kolčić; Liz Grant; Kit Yee Chan
Journal:  J Glob Health       Date:  2012-12       Impact factor: 4.413

Review 10.  Epilepsy care guidelines for low- and middle- income countries: From WHO mental health GAP to national programs.

Authors:  Juri Katchanov; Gretchen L Birbeck
Journal:  BMC Med       Date:  2012-09-24       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.